A detailed history of Richmond Brothers, Inc. transactions in Alvotech stock. As of the latest transaction made, Richmond Brothers, Inc. holds 13,966 shares of ALVO stock, worth $178,066. This represents 0.35% of its overall portfolio holdings.

Number of Shares
13,966
Holding current value
$178,066
% of portfolio
0.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$11.4 - $14.51 $159,212 - $202,646
13,966 New
13,966 $169,000

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.17B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track This Portfolio

Track Richmond Brothers, Inc. Portfolio

Follow Richmond Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.